Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endocrine adjuvant therapy for breast cancer.
Goldhirsch A, Gelber RD, Tattersall MN, Rudenstam CM, Cavalli F. Goldhirsch A, et al. Among authors: cavalli f. Lancet. 1985 Jun 1;1(8440):1274. doi: 10.1016/s0140-6736(85)92340-2. Lancet. 1985. PMID: 2860469 Clinical Trial. No abstract available.
Adjuvant therapy in postmenopausal node-positive breast cancer.
Goldhirsch A, Gelber RD, Cavalli F, Rudenstam CM, Tattersall MN. Goldhirsch A, et al. Among authors: cavalli f. J Clin Oncol. 1985 Jul;3(7):1045-7. doi: 10.1200/JCO.1985.3.7.1045. J Clin Oncol. 1985. PMID: 4020404 No abstract available.
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
Pagani O, O'Neill A, Castiglione M, Gelber RD, Goldhirsch A, Rudenstam CM, Lindtner J, Collins J, Crivellari D, Coates A, Cavalli F, Thürlimann B, Simoncini E, Fey M, Price K, Senn HJ. Pagani O, et al. Among authors: cavalli f. Eur J Cancer. 1998 Apr;34(5):632-40. doi: 10.1016/s0959-8049(97)10036-3. Eur J Cancer. 1998. PMID: 9713266 Clinical Trial.
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Thürlimann B, Price KN, Coates AS, Hürny C, Bernhard J, Lindtner J, Collins J, Senn HJ, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Goldhirsch A. Crivellari D, et al. Among authors: cavalli f. J Clin Oncol. 2000 Apr;18(7):1412-22. doi: 10.1200/JCO.2000.18.7.1412. J Clin Oncol. 2000. PMID: 10735888 Clinical Trial.
[Hormone receptors and breast cancer].
Goldhirsch A, Leuenberger U, Cavalli F. Goldhirsch A, et al. Among authors: cavalli f. Gynakol Rundsch. 1981;21(1):18-23. Gynakol Rundsch. 1981. PMID: 6268487 German. No abstract available.
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.
Giobbie-Hurder A, Price KN, Gelber RD; International Breast Cancer Study Group; BIG 1-98 Collaborative Group. Giobbie-Hurder A, et al. Clin Trials. 2009 Jun;6(3):272-87. doi: 10.1177/1740774509105380. Clin Trials. 2009. PMID: 19528136 Free PMC article. Clinical Trial.
643 results